Research Site

Seongnam-si, Gyeonggido 463-707

1 studies enrolling now · 10 studies all time

What they study most

Anemia, Asthma, Breast Cancer, COPD, CRC, Chronic Obstructive Pulmonary Disease, Dialysis-Dependent Chronic Kidney Disease, Hepatocellular Carcinoma, Idiopathic Pulmonary Fibrosis, NSCLC, Non-Dialysis-Dependent Chronic Kidney Disease, Prostate Cancer

Studies at this site

• Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis — Recruiting now
• Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma — Running, not enrolling
• Study to Evaluate D-1553 in Subjects With Solid Tumors — Running, not enrolling
• Observational Study of Obstructive Lung Disease (NOVELTY) — Completed
• Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Participants With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD) — Completed
• Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Participants With Dialysis-dependent Chronic Kidney Disease (DD-CKD) — Completed
• Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Participants With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD) — Completed
• An Efficacy and Safety Study of BG00011 in Participants With Idiopathic Pulmonary Fibrosis — Stopped early
• International Breast Cancer Biomarker,Standard of Care and Real World Outcomes Study — Completed
• A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Hormone Resistant Prostate Cancer With Bone Metastases — Completed